J E Roulston
Overview
Explore the profile of J E Roulston including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roulston J
Methods Mol Med
. 2011 Feb;
39:109-20.
PMID: 21340761
Since ancient times, cancer has been known to humankind. The ancient Greeks and Romans have left us with writings in which various treatment options are discussed (1). Disease processes and...
2.
Roulston J
Mol Biotechnol
. 2002 Mar;
20(2):153-62.
PMID: 11876472
Reviewing the literature it would appear that tumor markers have often flattered to deceive. Early promise does not often seem to be borne out in extended trials. Despite apparently high...
3.
Adam D, Milne A, Evans S, Roulston J, Lee A, Ruckley C, et al.
J Vasc Surg
. 1999 Aug;
30(2):229-35.
PMID: 10436442
Objective: Previous work has suggested that hyperamylasemia in patients who undergo operation for ruptured abdominal aortic aneurysm (AAA) is associated with poor outcome. The aims of this study were to...
4.
5.
Ng J, Sturgeon C, Seth J, Paterson G, Roulston J, Leonard R
Dis Markers
. 1993 Dec;
11(5-6):217-23.
PMID: 8082311
Three serum markers, TPS, CA 15.3 and CEA, were used to monitor the response to treatment of 20 patients with metastatic breast cancer. At the time of the first evidence...
6.
Fayers P, Rustin G, Wood R, Nelstrop A, Leonard R, Wilkinson P, et al.
Int J Gynecol Cancer
. 1993 Sep;
3(5):285-292.
PMID: 11578359
A number of studies have suggested that serum CA 125 levels may be an important prognostic factor for survival of patients with ovarian carcinoma. We investigated, in a large group...
7.
Beattie G, Sturgeon C, Fisken J, Roulston J
Ann Clin Biochem
. 1993 Jul;
30 ( Pt 4):402-3.
PMID: 8379653
No abstract available.
8.
Fisken J, Leonard R, Stewart M, Beattie G, Sturgeon C, Aspinall L, et al.
Br J Cancer
. 1993 Jul;
68(1):140-5.
PMID: 8318405
We examined the prognostic value of early serum CA125 assay in 58 patients with advanced epithelial ovarian cancer together with residual disease, age, tumour grade, performance status, and the presence...
9.
Fisken J, Roulston J, Sturgeon C, Badley R, Jonrup I, Aspinall L, et al.
Br J Cancer
. 1993 May;
67(5):1065-70.
PMID: 8494699
We assayed serum HMFG2 in serial samples from 215 primary epithelial ovarian cancer patients using an 'in-house' single determinant ELISA, 45% of patients with stage I, 54% with stage II,...
10.
Fisken J, Leonard R, Roulston J
Ann Oncol
. 1993 Mar;
4(3):257.
PMID: 8471561
No abstract available.